Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
5
×
national blog main
biotech
fda
amgen
boston blog main
drugs
eli lilly
migraine
national top stories
new york blog main
abbvie
akcea therapeutics
akouos
allergan
anylam pharmaceuticals
astellas pharmaceuticals
bempedoic acid
biohaven
boston
boston top stories
calcitonin gene-related peptide
california institute for biomedical research
cardiomyopathy
cgpr
cholesterol
chronic migraine
corticosteroids
deals
decibel therapeutics
detroit
detroit blog main
detroit top stories
episodic migraine
esperion therapeutics
europe blog main
ezetimibe
fluoroquinolones
frequency therapeutics
What
approved
5
×
fda
medicines
5
×
drug
class
migraine
new
nod
pill
therapeutics
treat
wins
adults
affects
ago
akcea
allergan
alnylam
americans
amyloidosis
announced
approval
attr
available
battle
cholesterol
combo
date
debilitating
decision
developed
developing
disease
eli
esperion
esperion’s
frequency
genetic
headache
hearing
Language
unset
Current search:
approved
×
medicines
×
" life sciences "
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
